Halozyme Therapeutics | HALO - Market Capitalization


Halozyme Therapeutics reported $13.79B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 195.44B 5.55B Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
Cara Therapeutics USD 30M 336M Mar/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
DBV Technologies USD 1.23B 327M Mar/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
MannKind USD 1.32B 559M Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Pfizer USD 138.44B 15.37B Jun/2026
United Therapeutics USD 23B 2.19B Jun/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024